{"gene":"GGPS1","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1999,"finding":"Human and mouse GGPS1 gene products catalyze the synthesis of geranylgeranyl diphosphate (GGPP) from isopentenyl diphosphate and farnesyl diphosphate as substrates, confirmed by in vitro enzymatic assay after expression in E. coli and by functional complementation (carotenoid synthesis) in co-transformation experiments.","method":"Recombinant protein expression in E. coli, in vitro enzymatic assay, functional complementation with carotenoid biosynthesis genes","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic reconstitution with defined substrates, validated by orthogonal carotenoid-synthesis functional assay","pmids":["10101267"],"is_preprint":false},{"year":2019,"finding":"Lung-specific knockout of GGPPS1 reduces GGPP levels, which decreases membrane localization of Rab10 and TLR4, inhibits IκB phosphorylation, and suppresses NLRP3 inflammasome activation (IL-1β release and pyroptosis), thereby attenuating LPS-induced acute lung injury.","method":"Lung-specific GGPPS1 knockout mice, LPS-induced ALI model, mRNA microarray, Western blot, immunofluorescence for membrane protein localization, in vitro cell studies","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean tissue-specific KO with defined cellular phenotypes and multiple pathway readouts, single lab","pmids":["30652497"],"is_preprint":false},{"year":2020,"finding":"Biallelic pathogenic variants in GGPS1 cause impaired geranylgeranylation of small GTPases; patient-derived myogenic cells show delayed membrane healing after laser injury, and a Y259C knock-in mouse results in prenatal lethality, establishing GGPS1 enzymatic function in the mevalonate/isoprenoid pathway as essential for muscle membrane repair.","method":"Whole exome sequencing, molecular modeling, biochemical analysis, laser membrane injury assay in patient-derived myogenic cells, Y259C knock-in mouse generation","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (biochemical analysis, functional cell assay, in vivo knock-in), replicated across 6 families","pmids":["32403198"],"is_preprint":false},{"year":2021,"finding":"Myometrial cell-specific deletion of Ggps1 impairs uterine contractions and causes dystocia; mechanistically, GGPS1-derived GGPP is required for RhoA geranylgeranylation (prenylation), which activates the RhoA/Rock2/p-MLC signaling pathway to enable uterine smooth muscle contraction. Supplementation with exogenous GGPP or farnesyl pyrophosphate rescues the defect.","method":"Conditional myometrial-specific Ggps1 knockout (Cre-loxP), uterine contraction assays, RhoA prenylation/membrane localization assays, GGPP/FPP supplementation rescue experiments","journal":"Journal of molecular cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific KO with defined molecular pathway (RhoA prenylation → Rock2 → p-MLC), rescue experiment providing mechanistic proof","pmids":["33340314"],"is_preprint":false},{"year":2017,"finding":"Chondrocyte-specific deletion of Ggps1 accelerates fracture healing by promoting endochondral ossification, calcification, and vasculogenesis via activation of the BMP2/Smad-dependent Runx2 pathway, indicating that GGPS1-derived GGPP normally suppresses this osteogenic pathway in chondrocytes.","method":"Tamoxifen-inducible Collagen 2-CreERT2 Ggps1 fl/fl conditional knockout mice, fracture healing model, histology, immunostaining, pathway analysis (BMP2/Smad/Runx2)","journal":"Journal of bone and mineral metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional cell-type-specific KO with defined pathway readout, single lab","pmids":["28357594"],"is_preprint":false},{"year":2022,"finding":"GGPPS1 knockout reduces expression of Rab37 in lung tissue, which restrains autophagy and attenuates ventilator-induced lung injury; Rab37 overexpression in GGPPS1 knockout cells restores autophagy, placing GGPPS1 upstream of Rab37-mediated autophagic signaling.","method":"Lung-specific GGPPS1 knockout mice, mechanical ventilation VILI model, transmission electron microscopy of autophagosomes, RAW264.7 cell knockdown, Rab37 overexpression rescue, rapamycin treatment","journal":"Human cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO model with rescue (Rab37 OE) and multiple autophagy readouts, single lab","pmids":["35334098"],"is_preprint":false},{"year":2021,"finding":"miR-182 targets GGPPS1 mRNA; catechin reactivates the miR-182/GGPPS1 signaling axis to reduce GGPPS1 expression and protect against LPS-induced acute lung injury in mice.","method":"In vivo LPS-ALI mouse model, CMAP drug identification, miR-182/GGPPS1 pathway analysis, cytokine measurement","journal":"Immunopharmacology and immunotoxicology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pathway inference from in vivo model without direct miR-182 binding validation reported in abstract, single lab, single study","pmids":["34845949"],"is_preprint":false},{"year":2026,"finding":"The rs3806394 variant in the GGPS1 promoter decreases GGPS1 promoter activity, leading to reduced GGPPS protein expression in renal cyst lining epithelium, which is independently associated with larger simple renal cyst size.","method":"Immunohistochemistry, Western blot, promoter activity assay (luciferase or equivalent), multivariate linear regression in 77 patients","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter activity assay demonstrating functional effect of variant on GGPS1 expression, supported by protein quantification in patient tissue","pmids":["41800173"],"is_preprint":false}],"current_model":"GGPS1 encodes geranylgeranyl diphosphate (GGPP) synthase, which catalyzes the production of GGPP from farnesyl diphosphate and isopentenyl diphosphate; GGPP is the obligate lipid donor for geranylgeranylation of small GTPases (including RhoA and Rab proteins), and GGPS1 loss disrupts RhoA/Rock2/p-MLC-dependent smooth muscle contraction, Rab10-mediated TLR4 membrane replenishment and NLRP3 inflammasome activation, Rab37-mediated autophagy, and BMP2/Smad/Runx2 osteogenic signaling, while biallelic mutations in specific GGPS1 domains cause a human syndrome of muscular dystrophy, sensorineural hearing loss, and ovarian insufficiency."},"narrative":{"mechanistic_narrative":"GGPS1 encodes geranylgeranyl diphosphate (GGPP) synthase, which catalyzes the synthesis of GGPP from farnesyl diphosphate and isopentenyl diphosphate, an activity established by in vitro enzymatic reconstitution and functional complementation [PMID:10101267]. GGPP is the obligate lipid donor for geranylgeranylation of small GTPases, and loss of GGPS1 impairs this prenylation across multiple tissues: in myometrial smooth muscle, GGPP is required for RhoA geranylgeranylation that drives the RhoA/Rock2/p-MLC contractile pathway, with exogenous GGPP or farnesyl pyrophosphate rescuing the contraction defect [PMID:33340314]. GGPS1-derived GGPP also controls the membrane localization and function of Rab GTPases—supporting Rab10/TLR4 membrane positioning and NLRP3 inflammasome activation [PMID:30652497] and restraining Rab37-mediated autophagy in lung injury [PMID:35334098]—and in chondrocytes it normally suppresses BMP2/Smad/Runx2 osteogenic signaling [PMID:28357594]. Biallelic pathogenic GGPS1 variants impair small-GTPase geranylgeranylation and delay myogenic membrane repair, causing a human syndrome with muscular dystrophy, while a Y259C knock-in is prenatally lethal in mice, establishing the enzyme as essential for muscle membrane healing and viability [PMID:32403198].","teleology":[{"year":1999,"claim":"Established the core biochemical identity of GGPS1 by showing its product catalyzes GGPP formation from defined isoprenoid substrates, defining the enzyme that supplies the geranylgeranyl lipid donor.","evidence":"Recombinant expression in E. coli with in vitro enzymatic assay and carotenoid-synthesis functional complementation","pmids":["10101267"],"confidence":"High","gaps":["Does not address tissue-specific roles or downstream prenylation targets","No structural basis for substrate specificity established"]},{"year":2017,"claim":"Showed that GGPS1-derived GGPP acts as a brake on osteogenic differentiation, linking the enzyme to BMP2/Smad/Runx2 signaling in chondrocytes.","evidence":"Tamoxifen-inducible Col2-CreERT2 chondrocyte-specific Ggps1 knockout in a fracture-healing model with pathway analysis","pmids":["28357594"],"confidence":"Medium","gaps":["The specific prenylated GTPase mediating BMP2 suppression is not identified","Single-lab finding without rescue by GGPP supplementation"]},{"year":2019,"claim":"Connected GGPP supply to innate immune signaling by showing GGPS1 loss mislocalizes Rab10 and TLR4 and dampens NLRP3 inflammasome activation.","evidence":"Lung-specific GGPPS1 knockout mice in an LPS acute lung injury model with membrane-localization immunofluorescence and pathway readouts","pmids":["30652497"],"confidence":"Medium","gaps":["Direct geranylgeranylation of Rab10 not biochemically demonstrated here","Single-lab study"]},{"year":2020,"claim":"Established human disease relevance and physiological essentiality by linking biallelic GGPS1 variants to impaired small-GTPase geranylgeranylation, defective muscle membrane repair, and embryonic lethality.","evidence":"Whole exome sequencing across 6 families, laser membrane-injury assay in patient myogenic cells, and Y259C knock-in mouse","pmids":["32403198"],"confidence":"High","gaps":["The specific GTPase whose under-prenylation causes membrane-repair failure is not pinpointed","Mechanism linking enzyme loss to hearing and ovarian phenotypes not resolved"]},{"year":2021,"claim":"Provided direct mechanistic proof that GGPP enables RhoA geranylgeranylation to drive smooth muscle contraction, with rescue establishing causality.","evidence":"Myometrial-specific Ggps1 knockout with RhoA prenylation/localization assays and GGPP/FPP supplementation rescue","pmids":["33340314"],"confidence":"High","gaps":["Whether the same RhoA axis operates in non-uterine smooth muscle not tested","Does not address other GGPP-dependent GTPases in the same tissue"]},{"year":2021,"claim":"Proposed upstream transcriptional/post-transcriptional control of GGPS1 via a miR-182 axis exploitable pharmacologically.","evidence":"In vivo LPS-ALI mouse model with CMAP drug identification and miR-182/GGPPS1 pathway analysis","pmids":["34845949"],"confidence":"Low","gaps":["Direct miR-182 binding to GGPS1 mRNA not validated","Single study, single lab"]},{"year":2022,"claim":"Positioned GGPS1 upstream of Rab37-dependent autophagy, showing its loss restrains autophagic signaling during ventilator-induced lung injury.","evidence":"Lung-specific GGPPS1 knockout with TEM autophagosome quantification and Rab37 overexpression rescue","pmids":["35334098"],"confidence":"Medium","gaps":["Whether GGPS1 controls Rab37 via prenylation or expression is not disentangled","Single-lab finding"]},{"year":2026,"claim":"Linked a regulatory GGPS1 promoter variant to reduced enzyme expression and a renal phenotype, extending functional consequences of GGPS1 dosage.","evidence":"Promoter activity (luciferase) assay, IHC/Western in patient tissue, and regression analysis in 77 patients","pmids":["41800173"],"confidence":"Medium","gaps":["Causal mechanism connecting reduced GGPP to cyst enlargement not defined","Correlative clinical association, modest cohort"]},{"year":null,"claim":"It remains unresolved how a single biochemical activity—GGPP synthesis—produces tissue-restricted phenotypes through distinct downstream GTPases, and which specific prenylation targets mediate the human disease manifestations.","evidence":"No single experiment in the corpus integrates the divergent RhoA/Rab pathways or assigns target specificity to each phenotype","pmids":[],"confidence":"Low","gaps":["No unified accounting of which GTPase under-prenylation drives muscle, hearing, and ovarian phenotypes","No structural model of substrate handling","No direct biochemical prenylation assay for each implicated GTPase in disease tissue"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0]}],"localization":[],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,4]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O95749","full_name":"Geranylgeranyl pyrophosphate synthase","aliases":["(2E,6E)-farnesyl diphosphate synthase","Dimethylallyltranstransferase","Farnesyl diphosphate synthase","Farnesyltranstransferase","Geranylgeranyl diphosphate synthase","Geranyltranstransferase"],"length_aa":300,"mass_kda":34.9,"function":"Catalyzes the trans-addition of the three molecules of IPP onto DMAPP to form geranylgeranyl pyrophosphate, an important precursor of carotenoids and geranylated proteins","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region; Cytoplasm, myofibril, sarcomere, Z line","url":"https://www.uniprot.org/uniprotkb/O95749/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/GGPS1","classification":"Common Essential","n_dependent_lines":1170,"n_total_lines":1208,"dependency_fraction":0.9685430463576159},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000152904","cell_line_id":"CID000279","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":1}],"interactors":[{"gene":"S100A7;S100A7A","stoichiometry":0.2},{"gene":"NCR3LG1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000279","total_profiled":1310},"omim":[{"mim_id":"619518","title":"MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO","url":"https://www.omim.org/entry/619518"},{"mim_id":"606982","title":"GERANYLGERANYL DIPHOSPHATE SYNTHASE 1; GGPS1","url":"https://www.omim.org/entry/606982"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GGPS1"},"hgnc":{"alias_symbol":["GGPPS1"],"prev_symbol":[]},"alphafold":{"accession":"O95749","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95749","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95749-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95749-F1-predicted_aligned_error_v6.png","plddt_mean":94.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GGPS1","jax_strain_url":"https://www.jax.org/strain/search?query=GGPS1"},"sequence":{"accession":"O95749","fasta_url":"https://rest.uniprot.org/uniprotkb/O95749.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95749/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95749"}},"corpus_meta":[{"pmid":"10101267","id":"PMC_10101267","title":"Identification of the GGPS1 genes encoding geranylgeranyl diphosphate synthases from mouse and human.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10101267","citation_count":37,"is_preprint":false},{"pmid":"30652497","id":"PMC_30652497","title":"Inhibition of GGPPS1 attenuated LPS-induced acute lung injury and was associated with NLRP3 inflammasome suppression.","date":"2019","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30652497","citation_count":33,"is_preprint":false},{"pmid":"32403198","id":"PMC_32403198","title":"GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome.","date":"2020","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32403198","citation_count":30,"is_preprint":false},{"pmid":"30680361","id":"PMC_30680361","title":"Incidence of Mutations in the ALPL, GGPS1, and CYP1A1 Genes in Patients With Atypical Femoral Fractures.","date":"2018","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/30680361","citation_count":25,"is_preprint":false},{"pmid":"24716791","id":"PMC_24716791","title":"GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis.","date":"2014","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24716791","citation_count":22,"is_preprint":false},{"pmid":"33340314","id":"PMC_33340314","title":"Ggps1 deficiency in the uterus results in dystocia by disrupting uterine contraction.","date":"2021","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/33340314","citation_count":9,"is_preprint":false},{"pmid":"35334098","id":"PMC_35334098","title":"Knockout of GGPPS1 restrains rab37-mediated autophagy in response to ventilator-induced lung injury.","date":"2022","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/35334098","citation_count":8,"is_preprint":false},{"pmid":"28357594","id":"PMC_28357594","title":"Knockdown of Ggps1 in chondrocyte expedites fracture healing by accelerating the progression of endochondral ossification in mice.","date":"2017","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28357594","citation_count":8,"is_preprint":false},{"pmid":"26734046","id":"PMC_26734046","title":"RNA Sequencing Analysis of the msl2msl3, crl, and ggps1 Mutants Indicates that Diverse Sources of Plastid Dysfunction Do Not Alter Leaf Morphology Through a Common Signaling Pathway.","date":"2015","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/26734046","citation_count":6,"is_preprint":false},{"pmid":"34845949","id":"PMC_34845949","title":"Catechin regulates miR-182/GGPPS1 signaling pathway and inhibits LPS-induced acute lung injury in mice.","date":"2021","source":"Immunopharmacology and immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/34845949","citation_count":5,"is_preprint":false},{"pmid":"37827345","id":"PMC_37827345","title":"CircUBR1 knockdown relieves ventilator-induced lung injury through regulating miR-20a-5p/GGPPS1 pathway.","date":"2023","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/37827345","citation_count":3,"is_preprint":false},{"pmid":"39165977","id":"PMC_39165977","title":"Pan-cancer analysis reveals GGPS1 plays an important role in tumorigenesis in multiple tumor types.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/39165977","citation_count":2,"is_preprint":false},{"pmid":"38129970","id":"PMC_38129970","title":"Expanding the phenotypic and genotypic spectrum of GGPS1 related congenital muscular dystrophy.","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/38129970","citation_count":1,"is_preprint":false},{"pmid":"41800173","id":"PMC_41800173","title":"GGPS1 Promoter Variant (rs3806394) Is Associated With Larger Simple Renal Cysts via Reduced GGPPS Expression.","date":"2026","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/41800173","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9432,"output_tokens":2185,"usd":0.030536,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9172,"output_tokens":2790,"usd":0.057805,"stage2_stop_reason":"end_turn"},"total_usd":0.088341,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"Human and mouse GGPS1 gene products catalyze the synthesis of geranylgeranyl diphosphate (GGPP) from isopentenyl diphosphate and farnesyl diphosphate as substrates, confirmed by in vitro enzymatic assay after expression in E. coli and by functional complementation (carotenoid synthesis) in co-transformation experiments.\",\n      \"method\": \"Recombinant protein expression in E. coli, in vitro enzymatic assay, functional complementation with carotenoid biosynthesis genes\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic reconstitution with defined substrates, validated by orthogonal carotenoid-synthesis functional assay\",\n      \"pmids\": [\"10101267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Lung-specific knockout of GGPPS1 reduces GGPP levels, which decreases membrane localization of Rab10 and TLR4, inhibits IκB phosphorylation, and suppresses NLRP3 inflammasome activation (IL-1β release and pyroptosis), thereby attenuating LPS-induced acute lung injury.\",\n      \"method\": \"Lung-specific GGPPS1 knockout mice, LPS-induced ALI model, mRNA microarray, Western blot, immunofluorescence for membrane protein localization, in vitro cell studies\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean tissue-specific KO with defined cellular phenotypes and multiple pathway readouts, single lab\",\n      \"pmids\": [\"30652497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Biallelic pathogenic variants in GGPS1 cause impaired geranylgeranylation of small GTPases; patient-derived myogenic cells show delayed membrane healing after laser injury, and a Y259C knock-in mouse results in prenatal lethality, establishing GGPS1 enzymatic function in the mevalonate/isoprenoid pathway as essential for muscle membrane repair.\",\n      \"method\": \"Whole exome sequencing, molecular modeling, biochemical analysis, laser membrane injury assay in patient-derived myogenic cells, Y259C knock-in mouse generation\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (biochemical analysis, functional cell assay, in vivo knock-in), replicated across 6 families\",\n      \"pmids\": [\"32403198\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Myometrial cell-specific deletion of Ggps1 impairs uterine contractions and causes dystocia; mechanistically, GGPS1-derived GGPP is required for RhoA geranylgeranylation (prenylation), which activates the RhoA/Rock2/p-MLC signaling pathway to enable uterine smooth muscle contraction. Supplementation with exogenous GGPP or farnesyl pyrophosphate rescues the defect.\",\n      \"method\": \"Conditional myometrial-specific Ggps1 knockout (Cre-loxP), uterine contraction assays, RhoA prenylation/membrane localization assays, GGPP/FPP supplementation rescue experiments\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific KO with defined molecular pathway (RhoA prenylation → Rock2 → p-MLC), rescue experiment providing mechanistic proof\",\n      \"pmids\": [\"33340314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Chondrocyte-specific deletion of Ggps1 accelerates fracture healing by promoting endochondral ossification, calcification, and vasculogenesis via activation of the BMP2/Smad-dependent Runx2 pathway, indicating that GGPS1-derived GGPP normally suppresses this osteogenic pathway in chondrocytes.\",\n      \"method\": \"Tamoxifen-inducible Collagen 2-CreERT2 Ggps1 fl/fl conditional knockout mice, fracture healing model, histology, immunostaining, pathway analysis (BMP2/Smad/Runx2)\",\n      \"journal\": \"Journal of bone and mineral metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional cell-type-specific KO with defined pathway readout, single lab\",\n      \"pmids\": [\"28357594\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GGPPS1 knockout reduces expression of Rab37 in lung tissue, which restrains autophagy and attenuates ventilator-induced lung injury; Rab37 overexpression in GGPPS1 knockout cells restores autophagy, placing GGPPS1 upstream of Rab37-mediated autophagic signaling.\",\n      \"method\": \"Lung-specific GGPPS1 knockout mice, mechanical ventilation VILI model, transmission electron microscopy of autophagosomes, RAW264.7 cell knockdown, Rab37 overexpression rescue, rapamycin treatment\",\n      \"journal\": \"Human cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO model with rescue (Rab37 OE) and multiple autophagy readouts, single lab\",\n      \"pmids\": [\"35334098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-182 targets GGPPS1 mRNA; catechin reactivates the miR-182/GGPPS1 signaling axis to reduce GGPPS1 expression and protect against LPS-induced acute lung injury in mice.\",\n      \"method\": \"In vivo LPS-ALI mouse model, CMAP drug identification, miR-182/GGPPS1 pathway analysis, cytokine measurement\",\n      \"journal\": \"Immunopharmacology and immunotoxicology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pathway inference from in vivo model without direct miR-182 binding validation reported in abstract, single lab, single study\",\n      \"pmids\": [\"34845949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"The rs3806394 variant in the GGPS1 promoter decreases GGPS1 promoter activity, leading to reduced GGPPS protein expression in renal cyst lining epithelium, which is independently associated with larger simple renal cyst size.\",\n      \"method\": \"Immunohistochemistry, Western blot, promoter activity assay (luciferase or equivalent), multivariate linear regression in 77 patients\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter activity assay demonstrating functional effect of variant on GGPS1 expression, supported by protein quantification in patient tissue\",\n      \"pmids\": [\"41800173\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GGPS1 encodes geranylgeranyl diphosphate (GGPP) synthase, which catalyzes the production of GGPP from farnesyl diphosphate and isopentenyl diphosphate; GGPP is the obligate lipid donor for geranylgeranylation of small GTPases (including RhoA and Rab proteins), and GGPS1 loss disrupts RhoA/Rock2/p-MLC-dependent smooth muscle contraction, Rab10-mediated TLR4 membrane replenishment and NLRP3 inflammasome activation, Rab37-mediated autophagy, and BMP2/Smad/Runx2 osteogenic signaling, while biallelic mutations in specific GGPS1 domains cause a human syndrome of muscular dystrophy, sensorineural hearing loss, and ovarian insufficiency.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GGPS1 encodes geranylgeranyl diphosphate (GGPP) synthase, which catalyzes the synthesis of GGPP from farnesyl diphosphate and isopentenyl diphosphate, an activity established by in vitro enzymatic reconstitution and functional complementation [#0]. GGPP is the obligate lipid donor for geranylgeranylation of small GTPases, and loss of GGPS1 impairs this prenylation across multiple tissues: in myometrial smooth muscle, GGPP is required for RhoA geranylgeranylation that drives the RhoA/Rock2/p-MLC contractile pathway, with exogenous GGPP or farnesyl pyrophosphate rescuing the contraction defect [#3]. GGPS1-derived GGPP also controls the membrane localization and function of Rab GTPases—supporting Rab10/TLR4 membrane positioning and NLRP3 inflammasome activation [#1] and restraining Rab37-mediated autophagy in lung injury [#5]—and in chondrocytes it normally suppresses BMP2/Smad/Runx2 osteogenic signaling [#4]. Biallelic pathogenic GGPS1 variants impair small-GTPase geranylgeranylation and delay myogenic membrane repair, causing a human syndrome with muscular dystrophy, while a Y259C knock-in is prenatally lethal in mice, establishing the enzyme as essential for muscle membrane healing and viability [#2].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the core biochemical identity of GGPS1 by showing its product catalyzes GGPP formation from defined isoprenoid substrates, defining the enzyme that supplies the geranylgeranyl lipid donor.\",\n      \"evidence\": \"Recombinant expression in E. coli with in vitro enzymatic assay and carotenoid-synthesis functional complementation\",\n      \"pmids\": [\"10101267\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address tissue-specific roles or downstream prenylation targets\", \"No structural basis for substrate specificity established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that GGPS1-derived GGPP acts as a brake on osteogenic differentiation, linking the enzyme to BMP2/Smad/Runx2 signaling in chondrocytes.\",\n      \"evidence\": \"Tamoxifen-inducible Col2-CreERT2 chondrocyte-specific Ggps1 knockout in a fracture-healing model with pathway analysis\",\n      \"pmids\": [\"28357594\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The specific prenylated GTPase mediating BMP2 suppression is not identified\", \"Single-lab finding without rescue by GGPP supplementation\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Connected GGPP supply to innate immune signaling by showing GGPS1 loss mislocalizes Rab10 and TLR4 and dampens NLRP3 inflammasome activation.\",\n      \"evidence\": \"Lung-specific GGPPS1 knockout mice in an LPS acute lung injury model with membrane-localization immunofluorescence and pathway readouts\",\n      \"pmids\": [\"30652497\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct geranylgeranylation of Rab10 not biochemically demonstrated here\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Established human disease relevance and physiological essentiality by linking biallelic GGPS1 variants to impaired small-GTPase geranylgeranylation, defective muscle membrane repair, and embryonic lethality.\",\n      \"evidence\": \"Whole exome sequencing across 6 families, laser membrane-injury assay in patient myogenic cells, and Y259C knock-in mouse\",\n      \"pmids\": [\"32403198\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific GTPase whose under-prenylation causes membrane-repair failure is not pinpointed\", \"Mechanism linking enzyme loss to hearing and ovarian phenotypes not resolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Provided direct mechanistic proof that GGPP enables RhoA geranylgeranylation to drive smooth muscle contraction, with rescue establishing causality.\",\n      \"evidence\": \"Myometrial-specific Ggps1 knockout with RhoA prenylation/localization assays and GGPP/FPP supplementation rescue\",\n      \"pmids\": [\"33340314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the same RhoA axis operates in non-uterine smooth muscle not tested\", \"Does not address other GGPP-dependent GTPases in the same tissue\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Proposed upstream transcriptional/post-transcriptional control of GGPS1 via a miR-182 axis exploitable pharmacologically.\",\n      \"evidence\": \"In vivo LPS-ALI mouse model with CMAP drug identification and miR-182/GGPPS1 pathway analysis\",\n      \"pmids\": [\"34845949\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Direct miR-182 binding to GGPS1 mRNA not validated\", \"Single study, single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Positioned GGPS1 upstream of Rab37-dependent autophagy, showing its loss restrains autophagic signaling during ventilator-induced lung injury.\",\n      \"evidence\": \"Lung-specific GGPPS1 knockout with TEM autophagosome quantification and Rab37 overexpression rescue\",\n      \"pmids\": [\"35334098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GGPS1 controls Rab37 via prenylation or expression is not disentangled\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Linked a regulatory GGPS1 promoter variant to reduced enzyme expression and a renal phenotype, extending functional consequences of GGPS1 dosage.\",\n      \"evidence\": \"Promoter activity (luciferase) assay, IHC/Western in patient tissue, and regression analysis in 77 patients\",\n      \"pmids\": [\"41800173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal mechanism connecting reduced GGPP to cyst enlargement not defined\", \"Correlative clinical association, modest cohort\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how a single biochemical activity—GGPP synthesis—produces tissue-restricted phenotypes through distinct downstream GTPases, and which specific prenylation targets mediate the human disease manifestations.\",\n      \"evidence\": \"No single experiment in the corpus integrates the divergent RhoA/Rab pathways or assigns target specificity to each phenotype\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified accounting of which GTPase under-prenylation drives muscle, hearing, and ovarian phenotypes\", \"No structural model of substrate handling\", \"No direct biochemical prenylation assay for each implicated GTPase in disease tissue\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":4,"faith_total":4,"faith_pct":100.0}}